| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus epidermidis (oxacillin-resistant) |
>16 |
>16 |
≤0.25 － >16 |
Clindamycin (Cleocin)  |
496 |
| Staphylococcus epidermidis (oxacillin-resistant) |
- |
4 |
0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
726 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
0.03 |
1 |
≤0.03 － >4 |
Trovafloxacin (Trovan) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
0.06 |
0.25 |
0.06 － >16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
496 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
0.12 |
0.5 |
≤0.06 － 0.5 |
Minocycline (Minocycline hydrochloride, Minocin) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
≤0.25 |
≤0.25 |
≤0.25 － >16 |
Clindamycin (Cleocin) |
496 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
0.25 |
0.5 |
≤0.06 － 1 |
Tigecycline (GAR-936, Tigacyl) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
0.25 |
2 |
≤0.06 － 4 |
Ampicillin (Omnipen) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
0.25 |
2 |
0.12 － 2 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
0.25 |
4 |
0.25 － >4 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
0.25 |
4 |
? － ? |
Meropenem (Merrem) |
171 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
>0.25 |
>8 |
0.25 － >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
496 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
≤0.5 |
≤0.5 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
>0.5 |
>4 |
≤0.5 － >4 |
Clindamycin (Cleocin) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
>0.5 |
>4 |
≤0.5 － >4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
≤1 |
≤1 |
≤1 － >4 |
Gentamicin (Gentamycin, Garamycin) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
≤1 |
≤1 |
≤1 － ? |
Imipenem |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
1 |
4 |
≤0.06 － 8 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
>1 |
>8 |
0.5 － >8 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
496 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
2 |
2 |
0.5 － 2 |
Ceftriaxone (Rocephin) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
≤2 |
≤2 |
≤2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
4 |
8 |
2 － 8 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
462 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
- |
4 |
0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
726 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
- |
- |
0.06 － 0.125 |
PD 0305970 |
225 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
- |
- |
0.06 － 4 |
Garenoxacin (T-3811, BMS-284756) |
225 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
- |
- |
0.125 － 0.25 |
PD 0326448 |
225 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
- |
- |
0.125 － 2 |
Gatifloxacin (Tequin) |
225 |
| Staphylococcus epidermidis (oxacillin-susceptible) |
- |
- |
0.25 － 16 |
Levofloxacin (Levaquin, Quixin) |
225 |